Latest IPO
Anthropic, PBC
- Offered980,000,000 securitiesChecked
- Raised$81,340,000,000before fees and costs, by the company and selling stockholdersChecked
When a company prices its IPO, we list the deal in plain English: how many shares, at what price, how much it raises and who ran the sale. Each figure links to the SEC filing it came from.
Latest IPO
Opinion Stockadora's take on each new IPO: the business and the deal, never whether to buy the stock. Written by an AI model from the checked facts on its page.
City Therapeutics is asking public investors to fund a science project that has barely entered human testing.
Reformation Inc. expects approximately $125.7 million in net proceeds from its share sale.
Csquare's debut is less about funding new construction and more about cleaning up the balance sheet.
GMR Solutions Inc.'s offering is less about funding new ambulances and more about paying down past obligations.
Suja Life sells health in a bottle, but its offering is mostly a balance-sheet cleanse.
Yesway has been waiting at the pump for a long time.
Newest first. Open one to see every term and where it came from.
| Company | Price | Shares sold | Raised | Filed |
|---|---|---|---|---|
| Anthropic, PBC | $83.00 | 980,000,000 | $81.3 billion | Nov 19 |
| Aspen Neuroscience, Inc.ASPE, Nasdaq Global Select Market | $15.00 | 9,375,000 | $140.6 million | Oct 30 |
| Bambusa Therapeutics, Inc.BBTX, Nasdaq Global Select Market | $16.00 | 10,555,555 | $168.9 million | Oct 30 |
| Lycia Therapeutics, Inc.LYCA, Nasdaq Global Select Market | $18.00 | 17,640,000 | $317.5 million | Oct 23 |
| CITY THERAPEUTICS, INC.CTY, Nasdaq Global Market | $18.00 | 11,111,111 | $200.0 million | Oct 16 |
| Amaero Inc.AMRO | $4.25 | 4,705,883 | $20.0 million | Oct 15 |
| Iambic Therapeutics, Inc.IAM, Nasdaq Global Select Market | $16.00 | 9,375,000 | $150.0 million | Oct 15 |
| Retension Pharmaceuticals, Inc.RTSN, Nasdaq Capital Market | $12.00 | 3,750,000 | $45.0 million | Oct 9 |
New to IPOs? These terms cover most of a deal page.
Every figure on a page has one of these labels and a source you can open.
Read from the filing, and the arithmetic holds: shares times price equals the total.
Taken from the document, but the SEC’s own data cannot confirm it yet. We say so on the page.
We could not find it with confidence, so there is no number. A blank beats a wrong answer.